Allied Biotech Corporation (TPEX:1780)

Market Cap	2.35B +43.0%
Revenue (ttm)	821.81M +3.9%
Net Income	94.59M -10.6%
EPS	0.98 -10.9%
Shares Out	96.24M
PE Ratio	24.89
Forward PE	n/a
Dividend	1.00 (4.10%)
Ex-Dividend Date	Jul 17, 2025

Volume	59,476
Average Volume	166,754
Open	24.40
Previous Close	24.75
Day's Range	24.20 - 24.50
52-Week Range	15.30 - 27.50
Beta	-0.06
RSI	45.29
Earnings Date	Mar 11, 2026

About Allied Biotech

Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. The company also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage applications; Lutei...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 40
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1780

Financial Performance

In 2024, Allied Biotech's revenue was 806.92 million, an increase of 12.00% compared to the previous year's 720.43 million. Earnings were 100.94 million, an increase of 3.62%.